CordenPharma
Pre-clinicalCordenPharma is a leading CDMO for cGMP development & manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligos, & osd.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $150M
About
CordenPharma is a leading CDMO for cGMP development & manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligos, & osd.
Small MoleculesBiologicsDrug Delivery
Funding History
1Total raised:$150M
Debt$150MMay 15, 2021